MKI67 and neoplasm: The tested expression variants allow the generation of two tumor categories; one includes tumors with higher differentiation, high Ki67, and low TGFß and MEK activity, while the second agglutinates those tumors enriched in genes related to invasive pathways and poor differentiation.